Crisdesalazine

N/A

Report date: 2025/03/28 11:42:47
NME

Base Information

Drug NameCrisdesalazine
Drug Alias NameCrisdesalalzineAAD-2004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E synthase inhibitorsReactive oxygen species scavengers
TargetsProstaglandin E synthaseReactive oxygen species
Therapy Area/IndicationsDepressionDiabetes MellitusAmyotrophic Lateral Sclerosis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGnt Pharma
China Registration ClassN/A

Develop Information

Active CompaniesToyota TsushoGlobal Neurotech
Inactive CompaniesN/A
Active IndicationsDepressionDiabetes MellitusAmyotrophic Lateral Sclerosis +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A